The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.20
Bid: 169.60
Ask: 170.20
Change: 6.20 (3.78%)
Spread: 0.60 (0.354%)
Open: 162.00
High: 170.60
Low: 162.00
Prev. Close: 164.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

24 Nov 2020 07:00

RNS Number : 2411G
Forterra plc
24 November 2020
 

24 November 2020

FORTERRA PLC

TRADING STATEMENT

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the four months ended 31 October 2020.

Trading and operational update

Trading in September and October exceeded our previous expectations, with brick and block revenues at 95% of the comparable prior year period. The recovery within the Bespoke Products division has also been sustained, with sales of our precast concrete floor beams remaining robust.

Trading has continued in a similar pattern through November, despite the start of a second national lockdown in England. Demand for our products has not been adversely affected with housebuilders encouraged to continue both the building and selling of homes, and builders' merchants remaining open to support tradesmen who are permitted to work on customers' properties. Production at our facilities, except the mothballed hollowcore flooring facility at Swadlincote, is running at pre-pandemic levels. As a result, the Board now anticipates 2020 EBITDA, stated before exceptional items, to be at least £34m, above the previously communicated range of £27m-£32m.

The construction of our new brick factory at Desford continues to progress although the recent insolvency of a supplier of manufacturing equipment and continued restrictions on travel from continental Europe have presented a number of challenges. Discussions with alternative suppliers are at an advanced stage and despite these challenges, at this time we continue to believe that the project can be delivered on time and on budget.

FY20 dividend

The Board remains confident that the Group is well placed to benefit from the strong long-term fundamentals of the residential construction market. Similarly, the Board has been encouraged by the recent recovery in trading and the generation of operating cashflow this has delivered. Accordingly, provided there continues to be no significant disruption to operations from the second wave of COVID-19, the Board now expects to recommend a final dividend for 2020 ahead of the 2021 AGM.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFDAEXEFFA
Date   Source Headline
2nd Mar 20224:32 pmRNSEmployee Benefit Trust Share Purchase
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:00 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research
25th Nov 20217:00 amRNSTrading Update
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.